ICD 10 CM C83.59 | Description & Clinical Information
ICD 10 C83.59 describes a type of non-Hodgkin lymphoma known as diffuse lymphoblastic lymphoma, which is characterized by the abnormal multiplication and scattering of B cell lymphocytes, white blood cells that produce antibodies to fight infection, throughout tissues other than the lymph nodes and involving solid organs, and is more commonly found in children and teenagers due to its fast-growing nature.
Official Description Of C83.59
The ICD 10 CM book defines ICD 10 code C83.59 as:
Excludes1: personal history of non-Hodgkin lymphoma (Z85.72)
When To Use C83.59
The diagnosis describes by the ICD-10 CM code C83.59 is a form of lymphoma known as diffuse large B-cell lymphoma (DLBCL). This type of cancer can originate in the lymph nodes but has the ability to spread and involve other tissues and organs in the body.
Patients with diffuse large B-cell lymphoma may present with enlarged lymph nodes as an early symptom. As the disease progresses, patients may also develop a large lump in the affected area which can be painful. Other symptoms can include fatigue, loss of appetite, night sweats, relapsing/remitting fever, and weight loss.
To diagnose diffuse large B-cell lymphoma, the healthcare provider must rely on the patient’s past medical history, physical examination, and laboratory tests. Blood tests may indicate decreased white blood cell counts (leukopenia) and an increased number of lymphocytes. However, the definitive diagnosis is made by analyzing a tissue sample from a lymph node biopsy under a microscope.
Diagnostic studies are also performed to determine the extent of involvement and stage of the disease. A complete blood cell (CBC) count, LDH, kidney function tests, and liver function tests are essential diagnostic tests to assess the extent of involvement. Further imaging studies like CT or PET are also important to determine the extent of malignancy.
The course of treatment depends on the stage and severity of the disease as well as the patient’s overall health. The most common treatment recommended by healthcare practitioners for diffuse large B-cell lymphoma is chemotherapy. However, in some advanced cases of diffuse large B-cell lymphoma, patients may require high dose chemotherapy combined with stem cell transplantation to help fight off the cancer.
It is crucial to diagnose and treat diffuse large B-cell lymphoma promptly as it can be a potentially life-threatening condition. Patients diagnosed with this form of lymphoma are advised to discuss treatment options with their healthcare provider to determine the best course of action for their situation. Early detection and prompt treatment can improve the patient’s chances of recovery while reducing the risk of complications.
